(Press-News.org) CHICAGO --- Walking barefoot on sand "felt like walking on glass" for Keith Wenckowski, who has lived with type-one diabetes for more than two decades.
One of the participants in a new Northwestern Medicine study who suffered from painful diabetic neuropathy (PDN), Wenckowski finally found relief from the constant foot pain that required him to wear shoes at all times, even to the beach.
The study found that those with PDN who received two low dose rounds of a non-viral gene therapy called VM202 had significant improvement of their pain that lasted for months.
"I can now go to a beach and walk on the sand without feeling like I am walking on glass," Wenckowski said.
The results of this phase two, double-blind, placebo-controlled study will be published March 5 in the journal Annals of Clinical and Translation Neurology.
Right now there is no treatment for this disease of the peripheral nerves that affects 20 to 25 percent of diabetics. Patients with the most extreme form of the disease feel intense pain with a slight graze or touch. The pain can interfere with daily activities, sleep, mood and can diminish quality of life.
"Those who received the therapy reported more than a 50 percent reduction in their symptoms and virtually no side effects," said Dr. Jack Kessler, lead author of the study. "Not only did it improve their pain, it also improved their ability to perceive a very, very light touch."
Kessler is the Ken and Ruth Davee Professor of Stem Cell Biology in the department of neurology and a professor in the department of pharmacology at Northwestern University Feinberg School of Medicine. He also is an attending physician at Northwestern Memorial Hospital.
VM202 contains human hepatocyte growth factor (HGF) gene. Growth factor is a naturally occurring protein in the body that acts on cells -- in this case nerve cells -- to keep them alive, healthy and functioning. Future study is needed to investigate if the therapy can actually regenerate damaged nerves, reversing the neuropathy.
Wenckowski had continuous numbness, but now, more than a year since he received the therapy, his symptoms have not returned. "I am hoping the effects I am feeling do not cease," he said.
Patients with painful diabetic neuropathy have abnormally high levels of glucose in their blood. These high levels of glucose can be toxic.
Damaged nerve cells send out abnormal signals, causing the patients to feel pain, usually in their lower limbs and fingertips. The condition can lead to injuries, chronic foot ulcers and even amputations.
Painkillers and other medications can alleviate symptoms, but those drugs often come with undesirable side effects.
"We are hoping that the treatment will increase the local production of hepatocyte growth factor to help regenerate nerves and grow new blood vessels and therefore reduce the pain," said Dr. Senda Ajroud-Driss, associate professor in neurology at Feinberg, an attending physician at Northwestern Memorial Hospital and an author of the study.
Eighty-four subjects with PDN completed this study. They went to a clinic twice in a two-week timespan for a series of injections into the back of their calf muscles and lower legs. Some received injections of a saline placebo, others a low dose of the therapy and others a higher dose.
"We found that the patients who received the low dose had a better reduction in pain than the people who received the high dose or the placebo," Ajroud-Driss said. "Side effects were limited to injection site reaction."
The subjects reported their pain symptoms to the researchers over the next nine months. At three months, patients in the low-dose group experienced a significant reduction in pain compared to the placebo group. The effect persisted at six and nine months in the low-dose group, the scientists said.
A future, much larger phase three study will soon be underway.
"Right now there is no medication that can reverse neuropathy," Kessler said. "Our goal is to develop a treatment. If we can show with more patients that this is a very real phenomenon, then we can show we have not only improved the symptoms of the disease, namely the pain, but we have actually improved function."
INFORMATION:
Methane is one hot gas. It's a prominent component of natural gas, an important atmospheric gas, and a product of both biology and chemical reactions. Its presence was recently confirmed in the atmosphere of Mars by NASA's Curiosity Rover and it has made the news both as a critical greenhouse gas and as a groundwater contaminant resulting from fracking. Yet, while methane seems to be everywhere, many questions remain about the reactions that produce and consume this high-energy compound.
"Deciphering the many pathways by which methane is produced is one of the holy grails ...
For the first time, CRISPR-Cas9 gene-editing technology has been employed in a whole organism model to systematically target every gene in the genome. A team of scientists at the Broad Institute and MIT's David H. Koch Institute for Integrative Cancer Research have pioneered the use of this technology to "knock out," or turn off, all genes across the genome systematically in an animal model of cancer, revealing genes involved in tumor evolution and metastasis and paving the way for similar studies in other cell types and diseases. The work appears online March 5 in Cell.
"Genome-scale ...
A molecule found in some plants can combat weight gain induced by a high-fat diet, but only in female mice, not males. 7,8-dihydroxyflavone (7,8-DHF) is thought to mimic the effects of a growth factor induced by exercise.
Emory researchers led by Keqiang Ye, PhD, have shown that female mice treated with 7,8-DHF could consume a high-fat diet without gaining weight. In the mice, 7,8-DHF could increase energy expenditure by acting on muscle cells, without suppressing appetite.
"An equivalent diet pill in humans would allow people to maintain a healthy weight, despite a ...
Did you know that our body produces its own marijuana-like compound to protect us against anxiety? A study led by Ottawa researchers, published today in Neuron, reveals a new biological pathway that regulates this system and suggests that a drug currently in clinical trials to treat obesity might also provide an attractive way to combat anxiety disorders.
"Anxiety and obesity are growing problems in society," said Dr. Hsiao-Huei Chen, associate professor of medicine at the University of Ottawa and a senior scientist at the Ottawa Hospital Research Institute. "Not only ...
Methane is a potent greenhouse gas, second only to carbon dioxide in its capacity to trap heat in Earth's atmosphere for a long time. The gas can originate from lakes and swamps, natural-gas pipelines, deep-sea vents, and livestock. Understanding the sources of methane, and how the gas is formed, could give scientists a better understanding of its role in warming the planet.
Now a research team led by scientists at MIT and including colleagues from the Woods Hole Oceanographic Institution, the University of Toronto, and elsewhere has developed an instrument that can ...
RIVERSIDE, Calif. - Soybean oil accounts for more than 90 percent of all the seed oil production in the United States. Genetically modified (GM) soybean oil, made from seeds of GM soybean plants, was recently introduced into the food supply on the premise that it is healthier than conventional soybean oil.
But is that premise true?
Just barely, say scientists at the University of California, Riverside and their colleagues at UC Davis. The researchers compared the effects of both oils in experiments performed in the lab on mice. They found that the GM soybean oil is ...
Astronomers have glimpsed a far off and ancient star exploding, not once, but four times.
The exploding star, or supernova, was directly behind a cluster of huge galaxies, whose mass is so great that they warp space-time. This forms a cosmic magnifying glass that creates multiple images of the supernova, an effect first predicted by Albert Einstein's General Theory of Relativity 100 years ago.
Dr Brad Tucker from The Australian National University (ANU) says it's a dream discovery for the team.
"It's perfectly set up, you couldn't have designed a better experiment," ...
Take a wild, common forest-dwelling mouse-like rodent, known as a vole, and subject it to 13 rounds of selection for increased aerobic exercise metabolism, and what do you get? A mighty "mouse" with a 48 percent higher peak rate of oxygen consumption and an increased basal metabolic rate, compared to unselected controls.
In a new study appearing in the advanced online edition of Molecular Biology and Evolution, authors Konczal et al. took advantage of an experimental evolution technique that has gained popularity, dubbed "evolve and resequence," to measure the genetic ...
The eastern coastline of Mexico's Yucatan Peninsula, a mecca for tourists, may have been walloped by a tsunami between 1,500 and 900 years ago, says a new study involving Mexico's Centro Ecological Akumal (CEA) and the University of Colorado Boulder.
There are several lines of evidence for an ancient tsunami, foremost a large, wedge-shaped berm about 15 feet above sea level paved with washing machine-sized stones, said the researchers. Set back in places more than a quarter of a mile from shore, the berm stretches for at least 30 miles, alternating between rocky headlands ...
Recent research from the Long Life Family Study (LLFS) confirms that severe mortality-associated diseases are less prevalent in the families of long-lived individuals than in the general population. The Journals of Gerontology, Series A® will publish these findings in the article titled, "Are Members of Long-Lived Families Healthier than Their Equally Long-Lived Peers? Evidence from the Long Life Family Study" on March 5, 2015. The LLFS is an international collaborative study of the genetics and familial components of exceptional survival, longevity, and healthy aging.
Researchers ...
